ScholarIQanswers from OpenAlex & ORCID
Willem A. Nolen
ResearcherPublications, citations & collaboration network
Willem A. Nolen is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Willem A. Nolen have?
ScholarIQindexed works
Willem A. Nolen has 454 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Willem A. Nolen have?
ScholarIQcitation count
Willem A. Nolen has 31,673 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Willem A. Nolen?
ScholarIQh-index
Willem A. Nolen has an h-index of 95 in OpenAlex.
What is the i10-index of Willem A. Nolen?
ScholarIQi10-index
Willem A. Nolen has an i10-index of 300 in OpenAlex.
What is the ORCID of Willem A. Nolen?
ScholarIQorcid
The ORCID for Willem A. Nolen is on the source record.
What is the OpenAlex record for Willem A. Nolen?
ScholarIQopenalex
The OpenAlex for Willem A. Nolen is on the source record.
What are the most-cited papers on Willem A. Nolen?
ScholarIQmost cited works
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013
Lakshmi N. Yatham, Sidney H. Kennedy, Sagar V. Parikh, Ayal Schaffer, Serge Beaulieu, Martin Alda, Claire O’Donovan, Glenda MacQueen, Roger S. McIntyre, Verinder Sharma, Arun Ravindran, L. Trevor Young, Roumen Milev, David J. Bond, Benício N. Frey, Benjamin I. Goldstein, Beny Lafer, Boris Birmaher, Kyooseob Ha, Willem A. Nolen, Michael Berk
The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods
Brenda W.J.H. Penninx, Aartjan T.F. Beekman, Johannes H. Smit, Frans G. Zitman, Willem A. Nolen, Philip Spinhoven, Pim Cuijpers, Peter J. de Jong, Harm van Marwijk, Willem JJ Assendelft, Klaas van der Meer, Peter Verhaak, Michel Wensing, Ron de Graaf, Witte J.G. Hoogendijk, Johan Ormel, Richard van Dyck
The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders
Isabella Pacchiarotti, David J. Bond, Ross J. Baldessarini, Willem A. Nolen, Heinz Grunze, Rasmus Wentzer Licht, Robert M. Post, Michael Berk, Guy M. Goodwin, Gary S. Sachs, Leonardo Tondo, Robert L. Findling, Eric A. Youngstrom, Mauricio Tohen, Juan Undurraga, Ana González‐Pinto, Joseph F. Goldberg, Ayşegül Yıldız, Lori L. Altshuler, Joseph R. Calabrese, Philip B. Mitchell, Michael E. Thase, Athanasios Koukopoulos, Francesc Colom, Mark A. Frye, Gin S. Malhi, Konstantinos Ν. Fountoulakis, Gustavo Vázquez, Roy H. Perlis, Terence A. Ketter, Frederick Cassidy, Hagop S. Akiskal, Jean-Michel Azorin, Marc Valentí, Diego Hidalgo‐Mazzei, Beny Lafer, Tadafumi Kato, Lorenzo Mazzarini, Anabel Martínez‐Arán, Gordon Parker, Daniel Souery, Ayşegül Özerdem, Susan L. McElroy, Paolo Girardi, Michael Bauer, Lakshmi N. Yatham, Carlos A. Zarate, Andrew A. Nierenberg, Boris Birmaher, Shigenobu Kanba, Rif S. El‐Mallakh, Alessandro Serretti, Zoltán Rihmer, Allan H. Young, Georgios D. Kotzalidis, Glenda MacQueen, Charles L. Bowden, S. Nassir Ghaemi, Carlos López‐Jaramillo, Janusz Rybakowski, Kyooseob Ha, Giulio Perugi, Siegfried Kasper, Jay D. Amsterdam, Robert M. A. Hirschfeld, Flávio Kapczinski, Eduard Vieta
Duration of major depressive episodes in the general population: Results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS)
Jan Spijker, Ron de Graaf, Rob Bijl, Aartjan T.F. Beekman, Johan Ormel, Willem A. Nolen